@gmj-georgia.bsky.socialA naturally occurring bacterium from amphibian intestines completely eliminated colorectal tumors in mice with a single dose—by combining di… #Cancertherapy #Colorectalcancer #Immunotherapy #Microbiome #Preclinicalresearch #Cancertherapy #Colorectalcancer #Immunotherapy #Microbiome #Preclinical…
@drtimos.bsky.social🚀 Get the #Oncology buzz from #ASCOGI25!
Top themes: #Efficacy 16.2%, #ClinicalTrials 16.1%, #Data 15.9%. #CRCsm & #GIOnc dominate, with #ctDNA & #Immunotherapy hot topics. 📊🩺
Download our full report! http://dlvr.it/TVs6b9
@ASCO
#SocialListening #LucidQuest
@newsen.bsky.socialAkeso Completes First Patient Dosing in Phase III Trial for Cadonilimab in Colon Cancer #Hong_Kong #Immunotherapy #Akeso #Cadonilimab
@newsramp.comBlood samples may soon replace surgical biopsies in developing personalized cancer immunotherapies, potentially expanding access for patients with hard-to-reach tumors. Clinical trials are underway to confirm the approach's efficacy. #Immunotherapy #CancerResearch
@carlus-2024.bsky.socialOctober 9, 2026
👉 What if a new immunotherapy approach could expand the number of patients who may benefit from CAR T-cell therapy against cancer?
🙂 Another encouraging news from Groupe UIG.
Read: www.uhnresearch.ca/news/10-07-2...
#Immunotherapy #Cancer #CART #GroupeUIG
@imtadvances.bsky.socialA simple whole-blood assay enables rapid, in vivo monitoring of engineered TCR T cell function, capturing cytokine responses post-transfer without complex processing. A practical step for tracking cell therapy performance. 🧬
@newsramp.comNew research shows tumor microenvironments actively reshape natural killer cells into distinct subsets — some exhausted, some potent memory-like killers. The findings could redefine precision cancer immunotherapy and accelerate next-gen NK cell treatments. #Oncology #Immunotherapy
@davidusharauli.bsky.socialVitamin intake has been linked to both cancer protection and promotion. Here, in a mouse CAR-T model, extra vitamin B2 (riboflavin) enhances antitumor effects by compensating for cancer-driven B2 deprivation.
@uhnresearch.ca2/ First authors: Evey Zheng and Dr. Chung-Hsi Wang
Senior author: Dr. Naoto Hirano
#CART #CancerResearch #Immunotherapy #Leukemia
--
@uhn.ca @aacrjournals.bsky.social
@sigtrans-sttt.bsky.socialNew first-line strategies are needed for metastatic #ColorectalCancer. The APICAL-CRC phase II trial finds promising #antitumor activity and manageable safety with sintilimab plus anlotinib in treatment-naïve patients.
#STTT #OpenAccess: doi.org/10.1038/s413...
#MetastaticCRC #Immunotherapy
@allermd.bsky.socialIn patients with #birch #pollen #allergy, a short course of investigational #immunotherapy before pollen season reduces the combined #symptom and #medication score compared with placebo. www.medscape.com/vie...
@genesndiseases.bsky.socialHow is #PDL1 controlled beyond transcription?
This review explores phosphorylation, ubiquitination, glycosylation and acetylation, revealing how their crosstalk shapes immune escape and may guide #BreastCancer #immunotherapy.
@imtadvances.bsky.socialA step forward in evolving cell therapies for AML: integrating TCR, CAR, BiTE, and safety switch into a single engineered T cell highlights how the field is moving toward multi-functional, adaptable designs to overcome tumor complexity.
@genesndiseases.bsky.socialWhy do some #LungCancer patients fail to benefit from PD-1/PD-L1 #immunotherapy?
This study identifies ANP32A as a regulator of #PDL1, showing that its loss enhances EP300/CREBBP activity and may influence treatment response.
#OpenAccess #GenesAndDiseases: doi.org/10.1016/j.ge...
@ashlesham89.bsky.socialThe global Melanoma Therapeutics Market is projected to grow from USD 11.25 billion in 2026 to USD 25.55 billion by 2034, at a 10.8% CAGR.
Get Free Sample:
straitsresearch.com/report/melan...
#Melanoma #CancerTherapeutics #Immunotherapy #Oncology #Healthcare #MarketResearch
@sigtrans-sttt.bsky.socialTargeting LRRC15+ tumor tissue may help dismantle mechanisms of #Immunotherapy resistance. DUNP19 enables radio-imaging and #Radiotherapy while suppressing pro-tumorigenic programs and potentiating checkpoint blockade. @uofcalifornia.bsky.social
#STTT #OpenAccess: doi.org/10.1038/s413...
@bionewscentral.comPreclinical study finds that blocking a protein makes #neuroblastoma cells easier for the #ImmuneSystem to detect and more vulnerable to #immunotherapy.
#ImmuneResponse #ImmunotherapyResponse
@genesndiseases.bsky.socialCould some microsatellite-stable #ColorectalCancers still respond to #immunotherapy?
This study identifies an “immune-enriched” subtype with greater immune infiltration, better survival and increased #antiPD1 sensitivity.
#OpenAccess in #GenesAndDiseases: doi.org/10.1016/j.ge...
@thecancersurvivorsclub.comCancer-fighting T cells can become exhausted before the job is done. Scientists have identified a way to help them conserve energy and keep fighting for longer, potentially improving several forms of immunotherapy.
@estroradiotherapy.bsky.social🔎 Coming up 13 October! Join this multidisciplinary webinar exploring how to combine #Radiotherapy & #Immunotherapy in #NSCLC — from biology and treatment timing to dose, volume and advanced RT techniques.
📅 13 Oct | 16:30–18:00 CEST | Online
👉 Reg: https://bit.ly/4hKH8D8
